Effect of Altitude on Polycythemia Vera: Is it Necessary to Change Limits?
High Altitude Medicine & Biology · 2025
DOI: 10.1089/ham.2025.0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift High Altitude Medicine & Biology, 2025. Verfasst von Istemi Serin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Agri Ibrahim Cecen University, Agri Training and Research Hospital, Agri, Turkey. Hauptthemen laut MEDLINE: Polycythemia Vera, Altitude, Hemoglobins. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Serin, Istemi, Ahmet Unal, Arzu Dobral, Fatma Elif Eroglu, Erdem Ayik, Jale Oz Unal, Mehmet Barış Cengiz, Okan Kati, Toros Taskin, Vural Bastug, and Abdulkadir Karismaz. The Effect of altitude on polycythemia vera: Is it necessary to change limits? High Alt Med Biol . 26:355–360, 2025.
Background
Polycythemia vera (PV) is a myeloproliferative disease characterized by high hemoglobin/hematocrit levels accompanied by JAK2 mutations. In this study, we aimed to establish a new hemoglobin cut-off value for the diagnosis and further evaluation of PV, taking into account the altitude of the regions where patients reside. In addition, we sought to examine the impact of altitude on patients diagnosed with PV and secondary polycythemia (SP) within our case series.
Methods
Patients living in Istanbul and Agri who were evaluated for PV at the hematology outpatient clinic of Istanbul and Agri Training and Research Hospitals between January 20, 2023, and January 20, 2024, were included in the study. The average altitude of the center of Agri is 1,630 m, while the center of Istanbul is 30 m.
Results
The mean altitude of residence for individuals diagnosed with PV was 326 ± 259 m, whereas it was significantly higher at 1,065 ± 675 m in the SP subgroup ( p < 0.001). However, in subgroup analyses of patients with PV and SP, altitude was not a significant factor influencing hemoglobin levels.
Conclusions
Our study results did not support the use of different hemoglobin cut-off values or correction factors for further evaluation of PV in patients living at different altitudes. Our results might not be applicable to altitudes higher than those we examined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Agri Ibrahim Cecen University, Agri Training and Research Hospital, Agri, Turkey.
- Department of Internal Medicine, Agri Ibrahim Cecen University, Agri Training and Research Hospital, Agri, Turkey.
- Department of Pathology, Agri Ibrahim Cecen University, Agri Training and Research Hospital, Agri, Turkey.
- Department of Geriatric Medicine, Dokuz Eylül University, Izmir, Turkey.
- Department of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey.
ORCID-Profile: Istemi Serin
Zitieren
APA
Serin, I., Unal, A., Dobral, A., Eroglu, F. E., Ayik, E., Unal, J. O., Cengiz, M. B., Kati, O., Taskin, T., Bastug, V., & Karismaz, A. (2025). Effect of Altitude on Polycythemia Vera: Is it Necessary to Change Limits?. High Altitude Medicine & Biology. https://doi.org/10.1089/ham.2025.0001
Vancouver
Serin I, Unal A, Dobral A, Eroglu FE, Ayik E, Unal JO, et al. Effect of Altitude on Polycythemia Vera: Is it Necessary to Change Limits?. High Altitude Medicine & Biology. 2025. doi:10.1089/ham.2025.0001
BibTeX
@article{Serin2025,
author = {Serin, Istemi and Unal, Ahmet and Dobral, Arzu and Eroglu, Fatma Elif and Ayik, Erdem and Unal, Jale Oz and Cengiz, Mehmet Barış and Kati, Okan and Taskin, Toros and Bastug, Vural and Karismaz, Abdulkadir},
title = {Effect of Altitude on Polycythemia Vera: Is it Necessary to Change Limits?},
journal = {High Altitude Medicine & Biology},
year = {2025},
doi = {10.1089/ham.2025.0001}
}
EUVIMED